Compile Data Set for Download or QSAR
Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 13594
TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809314BDBM809314((S)-4-(1-(5-(3-(1,1-difluoroethyl)-4-fluorophenoxy...)
Affinity DataKi:  2.20nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809312BDBM809312((S)-4-(1-(5-(3-(1,1-difluoroethyl)phenoxy)-3-(difl...)
Affinity DataKi:  2.90nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809241BDBM809241((S)-4-(1-(3-(difluoromethyl)-5-(3-ethyl-4-fluoroph...)
Affinity DataKi:  3nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809315BDBM809315((S)-4-(1-(5-(4-chloro-3-ethylphenoxy)-3-(difluorom...)
Affinity DataKi:  3.70nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809311BDBM809311((S)-4-(1-(3-(difluoromethyl)-5-(3-isopropylphenoxy...)
Affinity DataKi:  4nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809314BDBM809314((S)-4-(1-(5-(3-(1,1-difluoroethyl)-4-fluorophenoxy...)
Affinity DataIC50: 4nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809310BDBM809310((S)-4-(1-(5-(3-cyclopropylphenoxy)-3-(difluorometh...)
Affinity DataKi:  4.90nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809312BDBM809312((S)-4-(1-(5-(3-(1,1-difluoroethyl)phenoxy)-3-(difl...)
Affinity DataIC50: 5.30nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809241BDBM809241((S)-4-(1-(3-(difluoromethyl)-5-(3-ethyl-4-fluoroph...)
Affinity DataIC50: 5.5nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809313BDBM809313((S)-4-(1-(3-(difluoromethyl)-1-methyl-5-(3-(2,2,2-...)
Affinity DataKi:  5.80nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809316BDBM809316(4-((1S)-1-(3-(difluoromethyl)-1-methyl-5-(3-(1,1,1...)
Affinity DataKi:  6.60nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809318BDBM809318((S)-4-(1-(3-(difluoromethyl)-1-methyl-5-(3-(methyl...)
Affinity DataKi:  6.60nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809315BDBM809315((S)-4-(1-(5-(4-chloro-3-ethylphenoxy)-3-(difluorom...)
Affinity DataIC50: 6.80nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809317BDBM809317(4-((1S)-1-(3-(difluoromethyl)-5-(4-fluoro-3-(1-hyd...)
Affinity DataKi:  7nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809321BDBM809321((S)-4-(1-(3-(difluoromethyl)-1-methyl-5-((5-(trifl...)
Affinity DataKi:  7.30nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809311BDBM809311((S)-4-(1-(3-(difluoromethyl)-5-(3-isopropylphenoxy...)
Affinity DataIC50: 7.40nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809216BDBM809216((S)-4-(1-(3-(difluoromethyl)-5-(3-ethylphenoxy)-1-...)
Affinity DataKi:  8.90nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809310BDBM809310((S)-4-(1-(5-(3-cyclopropylphenoxy)-3-(difluorometh...)
Affinity DataIC50: 9nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809313BDBM809313((S)-4-(1-(3-(difluoromethyl)-1-methyl-5-(3-(2,2,2-...)
Affinity DataIC50: 11nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809318BDBM809318((S)-4-(1-(3-(difluoromethyl)-1-methyl-5-(3-(methyl...)
Affinity DataIC50: 12nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809316BDBM809316(4-((1S)-1-(3-(difluoromethyl)-1-methyl-5-(3-(1,1,1...)
Affinity DataIC50: 12nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809317BDBM809317(4-((1S)-1-(3-(difluoromethyl)-5-(4-fluoro-3-(1-hyd...)
Affinity DataIC50: 13nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809321BDBM809321((S)-4-(1-(3-(difluoromethyl)-1-methyl-5-((5-(trifl...)
Affinity DataIC50: 13nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809320BDBM809320(US12643889, Compound I-35)
Affinity DataKi:  15nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 119448BDBM119448(US8686018, 107 | US12643889, Compound Control)
Affinity DataKi:  16nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809216BDBM809216((S)-4-(1-(3-(difluoromethyl)-5-(3-ethylphenoxy)-1-...)
Affinity DataIC50: 16nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809319BDBM809319((S)-4-(1-(3-(difluoromethyl)-1-methyl-5-(3-(2,2,2-...)
Affinity DataKi:  17nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809320BDBM809320(US12643889, Compound I-35)
Affinity DataIC50: 28nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 119448BDBM119448(US8686018, 107 | US12643889, Compound Control)
Affinity DataIC50: 30nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent

TargetProstaglandin E2 receptor EP4 subtype(Human)
Wuhan Humanwell Innovative Drug Research And Development Center

US Patent
LigandChemical structure of BindingDB Monomer ID 809319BDBM809319((S)-4-(1-(3-(difluoromethyl)-1-methyl-5-(3-(2,2,2-...)
Affinity DataIC50: 31nMAssay Description:The bindings, to the radioligand EP4, of a control compound and the compounds prepared by Examples 1 to 43 were tested using recombinant human EP4 re...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
10/19/2026
Entry Details
US Patent